| Product dosage: 250mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 90 | $0.45 | $40.16 (0%) | 🛒 Add to cart |
| 120 | $0.37 | $53.55 $44.18 (18%) | 🛒 Add to cart |
| 180 | $0.30 | $80.32 $54.22 (32%) | 🛒 Add to cart |
| 360 | $0.22
Best per pill | $160.65 $79.32 (51%) | 🛒 Add to cart |
| Product dosage: 500mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.17 (0%) | 🛒 Add to cart |
| 90 | $0.55 | $64.76 $49.20 (24%) | 🛒 Add to cart |
| 120 | $0.46 | $86.35 $55.22 (36%) | 🛒 Add to cart |
| 180 | $0.38 | $129.52 $68.27 (47%) | 🛒 Add to cart |
| 270 | $0.32 | $194.28 $86.35 (56%) | 🛒 Add to cart |
| 360 | $0.29
Best per pill | $259.04 $104.42 (60%) | 🛒 Add to cart |
| Product dosage: 750mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $1.97 | $59.24 (0%) | 🛒 Add to cart |
| 60 | $1.39 | $118.48 $83.33 (30%) | 🛒 Add to cart |
| 90 | $1.18 | $177.71 $106.43 (40%) | 🛒 Add to cart |
| 120 | $1.09 | $236.95 $130.52 (45%) | 🛒 Add to cart |
| 180 | $0.99 | $355.43 $177.71 (50%) | 🛒 Add to cart |
| 360 | $0.88
Best per pill | $710.86 $318.28 (55%) | 🛒 Add to cart |
Synonyms | |||
Similar products
More info:
Cipro: Potent Antibiotic Treatment for Bacterial Infections
Cipro (ciprofloxacin) is a broad-spectrum fluoroquinolone antibiotic prescribed to combat a wide range of bacterial infections. Its mechanism of action involves inhibiting bacterial DNA gyrase and topoisomerase IV enzymes, effectively preventing bacterial replication and leading to cell death. This makes it a first-line treatment for numerous serious infections when other antibiotics may prove ineffective. Healthcare providers rely on Cipro for its proven efficacy against both gram-positive and gram-negative organisms. Features Active ingredient: Ciprofloxacin hydrochloride Available forms: Oral tablets (100mg, 250mg, 500mg, 750mg), extended-release tablets, oral suspension, and intravenous solution Broad-spectrum activity against aerobic gram-positive and gram-negative bacteria Rapid absorption with excellent tissue penetration Bioavailability of approximately 70% when taken orally Half-life of approximately 4 hours in patients with normal renal function Benefits Effective treatment for complicated urinary tract infections and pyelonephritis Rapid resolution of symptoms in appropriate bacterial infections High success rates in treating respiratory infections including exacerbations of chronic bronchitis Proven efficacy in skin and skin structure infections Effective against certain sexually transmitted diseases when caused by susceptible organisms Useful in treating bone and joint infections caused by susceptible bacteria Common use Cipro is commonly prescribed for urinary tract infections, including complicated cases and pyelonephritis.
CiproDex Ophthalmic Solution: Dual-Action Infection and Inflammation Control
CiproDex Ophthalmic Solution is a sterile, combination antimicrobial and anti-inflammatory suspension indicated for the treatment of ocular infections accompanied by significant inflammatory response. It combines ciprofloxacin, a broad-spectrum fluoroquinolone antibiotic, with dexamethasone, a potent corticosteroid, to address both the infectious pathogen and the associated inflammation. This formulation is designed for topical ophthalmic use and is available only by prescription. It is manufactured under stringent aseptic conditions to ensure sterility, potency, and patient safety.
AlfaCip: Advanced Ciprofloxacin Therapy for Severe Bacterial Infections
AlfaCip (ciprofloxacin hydrochloride) represents a potent fluoroquinolone antibiotic formulation designed for the systemic treatment of complicated bacterial infections. This broad-spectrum antimicrobial agent demonstrates exceptional bioavailability and tissue penetration, making it particularly effective against gram-negative pathogens and certain gram-positive organisms. Manufactured under strict pharmaceutical standards, AlfaCip ensures consistent dosing and reliable therapeutic outcomes in both hospital and outpatient settings. Its optimized pharmacokinetic profile allows for effective bacterial eradication while maintaining an acceptable safety margin when administered according to prescribed guidelines.
Ciloxan Ophthalmic Solution: Potent Antibiotic Relief for Eye Infections
Ciloxan (ciprofloxacin hydrochloride ophthalmic solution) 0.3% is a sterile, topical antimicrobial solution formulated for the treatment of ocular infections caused by susceptible strains of microorganisms. As a fluoroquinolone antibiotic, it offers a broad spectrum of bactericidal activity, effectively targeting both gram-positive and gram-negative bacteria. Its optimized formulation ensures high corneal penetration and sustained therapeutic levels, making it a first-line choice for ophthalmologists in managing bacterial conjunctivitis and corneal ulcers. This product is designed for precise ophthalmic application, minimizing systemic absorption and maximizing localized efficacy.
Ciplox: Effective Broad-Spectrum Antibiotic Treatment
Ciplox (ciprofloxacin) is a potent fluoroquinolone antibiotic designed to combat a wide range of bacterial infections. As a trusted prescription medication, it works by inhibiting bacterial DNA gyrase and topoisomerase IV, enzymes essential for bacterial DNA replication, transcription, and repair. This mechanism ensures rapid bactericidal action against both gram-positive and gram-negative organisms, making it a first-line choice for numerous infections when susceptibility is confirmed. Proper medical supervision is essential to maximize efficacy and minimize potential risks associated with fluoroquinolone therapy.
Clozaril: Atypical Antipsychotic for Treatment-Resistant Schizophrenia
Clozaril (clozapine) represents a significant advancement in the pharmacological management of treatment-resistant schizophrenia. As the first atypical antipsychotic approved by the FDA, it operates through a unique receptor binding profile distinct from conventional antipsychotics. Its efficacy in cases where other antipsychotics have failed establishes it as a critical therapeutic option. Strict monitoring protocols are mandatory due to its associated risk profile, particularly concerning agranulocytosis. This medication requires a dedicated treatment partnership between healthcare providers, patients, and caregivers to ensure both safety and optimal clinical outcomes.
Esbriet Slows Idiopathic Pulmonary Fibrosis Progression
Esbriet (pirfenidone) is an oral antifibrotic medication specifically indicated for the treatment of idiopathic pulmonary fibrosis (IPF). It is a disease-modifying agent that targets the underlying pathological processes of IPF, working to slow the decline in lung function. By reducing the rate of forced vital capacity (FVC) decline, Esbriet helps to preserve patients’ functional capacity and may improve long-term outcomes in this progressive and ultimately fatal condition. Treatment is managed by specialist physicians within a comprehensive care plan.
Eulexin: Advanced Androgen Blockade for Prostate Cancer Management
Eulexin (flutamide) is a nonsteroidal antiandrogen medication indicated for use in combination therapy for the management of metastatic prostate carcinoma. It functions by competitively inhibiting the uptake and binding of androgens, specifically dihydrotestosterone (DHT), to their receptors in target tissues. This targeted mechanism makes it a cornerstone in the pharmacological approach to hormone-sensitive prostate cancer, often used alongside a luteinizing hormone-releasing hormone (LHRH) agonist like leuprolide. By effectively reducing androgen stimulation of prostate cancer cells, Eulexin helps slow disease progression, manage symptoms, and improve quality of life in appropriate patient populations.
Loxitane: Advanced Antipsychotic Therapy for Schizophrenia Management
Loxitane (Loxapine) represents a significant advancement in the pharmacological management of schizophrenia and related psychotic disorders. As a first-generation dibenzoxazepine antipsychotic, it functions primarily as a dopamine D2 receptor antagonist, effectively modulating dopaminergic neurotransmission in the mesolimbic pathway. Its well-established efficacy profile and predictable pharmacokinetics make it a cornerstone treatment option for clinicians specializing in psychopharmacology. This agent provides a critical balance between therapeutic effectiveness and a manageable side effect profile, particularly for patients requiring long-term neuroleptic intervention.